• Profile
Close

A prospective pilot study comparing the anesthetic effects of an alpha-2 agonist during holmium laser resection of the prostate and transurethral resection for prostate surgery for benign prostatic hyperplasia patients using selective alpha-1 blockers

BMC Anesthesiology Oct 06, 2018

Lee DW, et al. - Among 69 consecutive patients undergoing transurethral prostate resection or holmium laser resection of the prostate under spinal anesthesia, researchers assessed the response to sedation with an α2receptor agonist in those using long-term selective α1 blockers. Study participants were divided into two groups: those who did not receive α1 blockers (group N; n=37) and those who received tamsulosin for at least 1 month before the study (group T; n=32). Bispectral index scores, Modified Observer’s Assessment of Alertness/Sedation scale scores, heart rate, and mean blood pressure levels were obtained under sedation using dexmedetomidine for 30 minutes during surgery. The researchers found that mean blood pressure levels 15 minutes following the first loading dose injection of dexmedetomidine were the only significant difference between the groups. They suggested that, for benign prostatic hyperplasia patients using tamsulosin, it may be appropriate to use α2 agonists during surgery, with no need for dose modification.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay